Rongjin Lin, chairman of Center Ventures and Center Laboratories shares his story of how he revived Center Laboratories from the brink of bankruptcy and repositioned the pharmaceutical company to become one of Taiwan’s leading biotechnology capital funds. Lin goes on to share his view on the Taiwanese biotech investment landscape, regional opportunities, and vision for the group’s future.
Our first investment was into PharmaEngine which several years later became a success story. Additionally, we invested in ten other corporations including Mycenax Biotech, Brim Biotechnology, and Eusol, most of which are IPOed today
